6-(4-(2-morpholinoethoxy)benzylidene)-6,7-dihydro-5H-indeno[5,6-d][1,3]dioxol-5-one

ID: ALA5284615

Max Phase: Preclinical

Molecular Formula: C23H23NO5

Molecular Weight: 393.44

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C1/C(=C/c2ccc(OCCN3CCOCC3)cc2)Cc2cc3c(cc21)OCO3

Standard InChI:  InChI=1S/C23H23NO5/c25-23-18(12-17-13-21-22(14-20(17)23)29-15-28-21)11-16-1-3-19(4-2-16)27-10-7-24-5-8-26-9-6-24/h1-4,11,13-14H,5-10,12,15H2/b18-11+

Standard InChI Key:  VWIPVRYNEVNROZ-WOJGMQOQSA-N

Molfile:  

 
     RDKit          2D

 29 33  0  0  0  0  0  0  0  0999 V2000
   -3.8041    1.1085    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0895    1.5208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3776    1.1089    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3776    0.2837    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0877   -0.1280    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8041    0.2800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5929    0.0287    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5928    1.3637    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1079    0.6962    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5920    1.3645    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5920    0.0240    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0789    0.6943    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3793    2.1609    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2826    0.6962    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1298   -0.0184    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9551   -0.0185    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3657   -0.7315    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9530   -1.4463    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1319   -1.4479    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2844   -0.7360    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3657   -2.1609    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1908   -2.1609    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6034   -1.4463    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4286   -1.4463    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.8412   -0.7317    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6664   -0.7317    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0789   -1.4463    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.6664   -2.1609    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8412   -2.1609    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  1  0
  4  3  2  0
  5  4  1  0
  1  6  1  0
  6  5  2  0
  4  7  1  0
  3  8  1  0
  8  9  1  0
  9  7  1  0
  1 10  1  0
  6 11  1  0
 11 12  1  0
 12 10  1  0
  8 13  2  0
  9 14  2  0
 14 15  1  0
 16 15  2  0
 17 16  1  0
 18 17  2  0
 19 18  1  0
 20 19  2  0
 15 20  1  0
 18 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 25 24  1  0
 26 25  1  0
 27 26  1  0
 28 27  1  0
 29 28  1  0
 24 29  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5284615

    ---

Associated Targets(Human)

A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCD 19Lu (25 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PANC-1 (6144 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CTSL Tclin Cathepsin L (3852 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CTSD Tchem Cathepsin D (3201 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 393.44Molecular Weight (Monoisotopic): 393.1576AlogP: 2.95#Rotatable Bonds: 5
Polar Surface Area: 57.23Molecular Species: NEUTRALHBA: 6HBD:
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 6.65CX LogP: 3.16CX LogD: 3.09
Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.73Np Likeness Score: -0.56

References

1. Altıntop MD, Özdemir A, Temel HE, Demir Cevizlidere B, Sever B, Kaplancıklı ZA, Akalın Çiftçi G..  (2022)  Design, synthesis and biological evaluation of a new series of arylidene indanones as small molecules for targeted therapy of non-small cell lung carcinoma and prostate cancer.,  244  [PMID:36270087] [10.1016/j.ejmech.2022.114851]

Source